shahla shojaei
Department of Surgery, Max Rady College of Medicine, University of Manitoba
Winnipeg, Canada
Review Editor
Cancer Molecular Targets and Therapeutics
Department of Surgery, Max Rady College of Medicine, University of Manitoba
Winnipeg, Canada
Review Editor
Cancer Molecular Targets and Therapeutics
Karolinska Institutet (KI)
Solna, Sweden
Review Editor
Cancer Molecular Targets and Therapeutics
Albert Einstein College of Medicine
New York City, United States
Review Editor
Cancer Molecular Targets and Therapeutics
Mayo Clinic
Rochester, United States
Review Editor
Cancer Molecular Targets and Therapeutics
The Ohio State University
Columbus, United States
Review Editor
Cancer Molecular Targets and Therapeutics
The Ohio State University
Columbus, United States
Review Editor
Cancer Molecular Targets and Therapeutics
The University of Newcastle
Callaghan, Australia
Review Editor
Cancer Molecular Targets and Therapeutics
Regina Elena National Cancer Institute, Hospital Physiotherapy Institutes (IRCCS)
Rome, Italy
Review Editor
Cancer Molecular Targets and Therapeutics
Children's Cancer Institute Australia
Randwick, Australia
Review Editor
Cancer Molecular Targets and Therapeutics
University of Milan
Milan, Italy
Review Editor
Cancer Molecular Targets and Therapeutics
Nanjing University
Nanjing, China
Review Editor
Cancer Molecular Targets and Therapeutics
Peking Union Medical College Hospital (CAMS)
Beijing, China
Review Editor
Cancer Molecular Targets and Therapeutics
Advent Health Orlando
Orlando, United States
Review Editor
Cancer Molecular Targets and Therapeutics
CICS-UBI – Health Science Research Centre, University of Beira Interior, Covilhã, Portugal
CovilhĂŁ, Portugal
Review Editor
Cancer Molecular Targets and Therapeutics
G. Pascale National Cancer Institute Foundation (IRCCS)
Naples, Italy
Review Editor
Cancer Molecular Targets and Therapeutics
Philadelphia College of Osteopathic Medicine (PCOM)
Philadelphia, United States
Review Editor
Cancer Molecular Targets and Therapeutics